Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Breast CancerMultiple MyelomaProstate Cancer
Interventions
DRUG

zoledronic acid

Trial Locations (7)

23294

Virginia Physicians, Inc, Richmond

34741

Osceola Cancer Center, Kissimmee

87102

Hematology-Oncology Associates PC, Albuquerque

New Mexico Oncology Hematology Consultants, Albuquerque

89109

Nevada Cancer Center, Las Vegas

95204

Stockton Hematology Oncology Medical Group, Stockton

97504

Hematology Oncology Associates, PC, Medforo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY